Colonic necrosis due to oral kayexalate in a critically-ill patient.

Author(s): Thomas A, James BR, Landsberg D

Affiliation(s): Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA. thomasan@upstate.edu

Publication date & source: 2009-04, Am J Med Sci., 337(4):305-6.

Publication type: Case Reports

Kayexalate (sodium polystyrene sulfonate in sorbitol) is commonly used for treatment of hyperkalemia. We describe the case of a critically ill patient who developed colonic necrosis after oral administration of kayexalate.